Breakthrough Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae during Combination Therapy with Colistin and Tigecycline

Ítems similars

• Characteristics and Clinical Outcomes of Extended-Spectrum beta-lactamase-producing Klebsiella pneumoniae Bacteremia in Cancer Patients
  per: Nham, Eliel, et al.
  Publicat: (2020)
• Reply to “Breakthrough Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae during Combination Therapy with Colistin and Tigecycline”
  per: Albur, Mahableshwar, et al.
  Publicat: (2012)
• Native valve endocarditis due to extended spectrum β-lactamase producing Klebsiella pneumoniae
  per: Jung, Hyun-Ae, et al.
  Publicat: (2014)
• Epidemiology of Ciprofloxacin Resistance and Its Relationship to Extended-Spectrum β-Lactamase Production in Proteus mirabilis Bacteremia
  per: Sohn, Kyung Mok, et al.
  Publicat: (2011)
• Emergence of serotype K1 Klebsiella pneumoniae ST23 strains co-producing the plasmid-mediated AmpC beta-lactamase DHA-1 and an extended-spectrum beta-lactamase in Korea
  per: Cheong, Hae Suk, et al.
  Publicat: (2016)